O'Byrne, Paul M <br/><br/>
Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study.  [electronic resource] 

 -  Respiratory research  Aug 2015 
 - 97 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1465-993X 
<br/><br/><label>Standard No.: </label>10.1186/s12931-015-0249-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Adrenergic beta-2 Receptor Agonists--administration & dosage<br/>Adult<br/>Asthma--diagnosis<br/>Benzoxazines--administration & dosage<br/>Cross-Over Studies<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Longitudinal Studies<br/>Male<br/>Middle Aged<br/>Treatment Outcome